IRIS
GROSA, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.231
NA - Nord America 4.067
AS - Asia 2.145
SA - Sud America 276
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 53
OC - Oceania 1
Totale 10.879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.978
RU - Federazione Russa 895
IE - Irlanda 764
CN - Cina 638
SG - Singapore 610
SE - Svezia 535
IT - Italia 523
DE - Germania 521
UA - Ucraina 358
HK - Hong Kong 292
VN - Vietnam 265
FI - Finlandia 216
BR - Brasile 210
FR - Francia 149
IN - India 116
GB - Regno Unito 114
KR - Corea 49
CA - Canada 46
TR - Turchia 36
BE - Belgio 32
IR - Iran 29
AR - Argentina 25
EE - Estonia 25
MX - Messico 25
BD - Bangladesh 20
CZ - Repubblica Ceca 18
ES - Italia 18
JP - Giappone 17
PL - Polonia 16
IQ - Iraq 15
ID - Indonesia 12
ZA - Sudafrica 12
EC - Ecuador 11
BJ - Benin 10
LT - Lituania 10
NL - Olanda 10
PK - Pakistan 10
EU - Europa 9
CL - Cile 8
MA - Marocco 8
CO - Colombia 5
PY - Paraguay 5
UZ - Uzbekistan 5
VE - Venezuela 5
AT - Austria 4
BG - Bulgaria 4
CH - Svizzera 4
EG - Egitto 4
HN - Honduras 4
PE - Perù 4
SA - Arabia Saudita 4
TH - Thailandia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
ET - Etiopia 3
GE - Georgia 3
GR - Grecia 3
MD - Moldavia 3
PH - Filippine 3
TN - Tunisia 3
BO - Bolivia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
NI - Nicaragua 2
NP - Nepal 2
PR - Porto Rico 2
RO - Romania 2
SV - El Salvador 2
AL - Albania 1
AO - Angola 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
SX - ???statistics.table.value.countryCode.SX??? 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 10.783
Salva come PNG Salva come JPEG
Città #
Dublin 764
Jacksonville 588
San Jose 328
Hong Kong 291
Dearborn 280
Chandler 261
Singapore 237
Beijing 223
Ashburn 209
Council Bluffs 181
Wilmington 155
Ann Arbor 147
Moscow 128
Piemonte 128
Lawrence 100
Los Angeles 100
Princeton 100
Lauterbourg 82
Ho Chi Minh City 81
San Mateo 81
Columbus 70
Andover 68
Munich 66
Hanoi 63
Buffalo 46
Seoul 45
New York 43
Philadelphia 40
Woodbridge 39
Bremen 36
Helsinki 35
Milan 33
Boardman 32
Brussels 32
Santa Clara 32
Houston 27
São Paulo 27
Hefei 24
Orem 24
Guangzhou 21
Frankfurt am Main 20
Nanjing 20
Chennai 19
Toronto 19
Dallas 18
Kocaeli 17
Brno 16
Monmouth Junction 15
Rome 15
Redondo Beach 14
Tokyo 14
Sacramento 13
Hangzhou 12
Tianjin 12
Warsaw 12
Denver 11
Norwalk 11
Seattle 11
Torino 11
Brooklyn 10
Chicago 10
Cotonou 10
Da Nang 10
Haiphong 10
Montreal 10
Nanchang 10
Turku 10
Ankara 9
Boston 9
Brasília 9
Jinan 9
London 9
Mexico City 9
Novara 9
Stockholm 9
Zhengzhou 9
Amsterdam 8
Dong Ket 8
Fairfield 8
Falkenstein 8
Johannesburg 8
Poplar 8
Shenyang 8
Zanjan 8
Ardabil 7
Biên Hòa 7
Chengdu 7
Kunming 7
Leawood 7
Manchester 7
Nuremberg 7
Atlanta 6
Baghdad 6
Guarulhos 6
Las Vegas 6
Mumbai 6
Nova Iguaçu 6
Phoenix 6
Salerno 6
San Francisco 6
Totale 5.875
Salva come PNG Salva come JPEG
Nome #
ELEMENTI DI GALENICA CON ESERCIZI DI TARIFFAZIONE 217
Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents 181
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group 176
Preparazioni galeniche Esercizi di tariffazione secondo la nuova TNM 175
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 173
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 168
Inhibitors of Nicotinamide Phosphoribosyltransferase, compositions, products and uses thereof. 164
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 164
A Concise Synthesis of Pyrazole Analogues of Combretastatin A1 as Potent Antitubulin Agents 162
Metabolic fate of combretastatin A-1: LC-DAD-MS/MS investigation and biological evaluation of its reactive metabolites 157
Are 1,4- and 1,5-Disubstituted 1,2,3-Triazoles Good Pharmacophoric Groups? 157
Development and validation of a stability-indicating HPLC-UV method for the determination of Thiocolchicoside and its degradation products 150
La spettrometria di massa negli studi di stabilità dei farmaci 147
CHEMICAL STABILITY STUDIES OF PROPARGYLAMINE-CONTAINING DRUGS 143
Biological effects of combined resveratrol and vitamin D3 on ovarian tissue 143
Identification of a Potent Phosphoinositide 3-Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its Prodrugs 140
DETERMINAZIONE HPLC SIMULTANEA DELLA GUAIFENESINA E DEL METILE E PROPILE p-IDROSSIBENZOATO IN UNA FORMULAZIONE LIQUIDA 134
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 134
Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues 131
Development and validation of a stability-indicating LC–UV method for the determination of pantethine and its degradation product based on a forced degradation study 131
FORCED DEGRADATION STUDY OF TIOCOLCHICOSIDE: HPLC-MS CHARACTERIZATION OF DEGRADATION PRODUCTS 130
New insights in oxybutynin chemical stability: Identification in transdermal patches of a new impurity arising from oxybutynin N-oxide rearrangement 127
CHEMICAL STABILITY STUDIES OF PROPARGYLAMINE CONTAINING-DRUGS 126
New insights in the metabolism of oxybutynin: evidence of N-oxidation of propargylamine moiety and rearrangement to enaminoketone 126
Elementi di galenica con esercizi di tariffazione 124
Development and validation of a stability-indicating HPLC-UV method for the determination of alizapride and its degradation products 122
2,3-epoxy-10-aza-10,11-dihydrosqualene, an high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase 121
A new approach in the synthesis of immunotoxins ribosome inactivating protein non covalently bound to monoclonal antibody 120
Azasqualene alcohol and derivatives new selective inhibitors of 2,3-oxidosqualene cyclase 116
DEVELOPMENT AND VALIDATION OF HPLC-UV STABILITY INDICATING METHOD FOR THE DETERMINATION OF THIOCOLCHICOSIDE AND ITS DEGRADATION PRODUCTS IN PHARMACEUTICAL DOSAGE FORM 116
2,3,4,5-tetrahydroxy-5- (4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling 115
FORCED DEGRADATION STUDY OF DOXOFYLLINE: HPLC-MS CHARACTERIZATION OF DEGRADATION PRODUCTS IN BULK DRUG 115
Troxerutin, a mixture of O-hydroxyethyl derivatives of the natural flavonoid rutin: Chemical stability and analytical aspects 115
Synthesis and antibronchospastic activity of theophylline thioacetal derivatives 114
3-carboxy-4-nitrophenyl-dithio-1,1',2-trisnorsqualene: a site-directed inactivator of yeast oxidosqualene cyclase 114
Synthesis of a squalenoid oxaziridine and other new classes of squalene derivatives, as inhibitors of sterol biosynthesis 113
Semicarbazide Hydrochloride as Impurity in Drug Substances: a Validated LC-DAD-UV Method for Its Determination in Carbazochrome and Carbazochrome Sodium Sulfonate 112
Development and validation of a solid-phase extraction and gas chromatography–tandem mass spectrometry method for the determination of isopropyl-9H-thioxanthen-9-one in carton packaged milk 111
Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis 111
IN VITRO METABOLISM STUDY OF ISOPROPYL-9H-THIOXANTHEN-9-ONE (ITX) IN RAT LIVER MICROSOMES 108
In vitro metabolism of 1,3-dioxane, 1,3-oxathiolane and 1,3-dithiane derivatives of theophylline: a structure-metabolism correlation study 107
New Hyaluronic Acid from Plant Origin to Improve Joint Protection—An In Vitro Study 106
2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors 106
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan 106
FORCED DEGRADATION OF DOXOFYLLINE IN BULK DRUG: IDENTIFICATION OF THREE DEGRADATION PRODUCTS 105
Thiol-modifying inhibitors for understanding squalene cyclase function 104
LC-ESI-MS/MS CHARACTERIZATION OF DEGRADATION PRODUCTS OF TROPANE ALKALOIDS IN BELLADONNA DRY EXTRACT 104
Forced degradation study of thiocolchicoside: Characterization of its degradation products 103
In vitro metabolism of Bumetanide 102
Kinetics of ABC-99 in the rat 101
An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline 99
Doxofylline in rat brain in relation to locomotor activity - Drug Metabolism and Disposition 99
A new "solid phase" procedure to synthetize immunotoxins 98
In vitro metabolism study of 2-isopropyl-9H-thioxanthen-9-one (2-ITX) in rat and human: evidence for the formation of an epoxide metabolite 98
Role of chocolate consumption in the inflammatory pathway: a proteomic approach 98
Drug design based on biosynthetic studies: synthesis, biological activity and kinetics of new inhibitors of 2,3-oxido squalene cyclase and squalene epoxidase 97
In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes 96
Metabolic Fate of the Isocyanide Moiety: Are Isocyanides Pharmacophore Groups Neglected by Medicinal Chemists? 96
IN VITRO METABOLIC FATE OF COMBRETASTATIN A-4: EVIDENCE FOR THE FORMATION OF A SULPHATE CONJUGATE METABOLITE 95
SIMULTANEOUS DETERMINATION OF SEROTONIN AND CATECHOLAMINES IN RAT BRAIN BY LC-MS/MS 94
2-aza-2,3-dihydrosqualene:biodistribution and pharmacokinetic properties in mice 93
FORCED DEGRADATION STUDY OF OXYBUTYNIN: NEW INSIGHTS FROM LC-MS/MS ANALYSIS ON ITS CHEMICAL STABILITY 92
LC-MS CHARACTERIZATION OF THE IN VITRO METABOLITES OF ALIZAPRIDE 91
Synthesis and biological activity of 19-azasqualene 2,3-epoxide as inhibitor of 2,3-oxidosqualene cyclase 90
IN VITRO METABOLISM OF ALIZAPRIDE: EVIDENCE FOR THE FORMATION OF ACROLEIN IN RAT LIVER MICROSOMES 90
In vitro metabolism of 2-(5-ethylpyridin-2-yl)benzimidazole 90
In vitro metabolic fate of alizapride: evidence for the formation of reactive metabolites based on liquid chromatography-tandem mass spectrometry 89
Metabolism of Doxophylline by rat liver microsomes 89
Nitroanilines are the reduction products of benzofuroxan system by oxyhemoglobin (HbO22+) 87
HPLC DETERMINATION OF DOXOFYLLINE AND ITS DEGRADATION PRODUCTS IN DRUG SUBSTANCE: DEVELOPMENT AND VALIDATION 86
IN VITRO, IN VIVO METABOLISM STUDY OF COMBRETASTATIN A-4 IN RAT AND HUMAN 86
Synthesis of squalenoid acetylenes and allenes, as inhibitors of squalene epoxidase 86
Metabolism of 4-(3-cyclohexylpropionyl)-1-(2-ethoxyphenyl)piperazine (D-16120) by rat liver microsomes 86
Synthesis and biological activity of a squalenoid maleimide and other classes of squalene derivatives as irreversible inhibitors of 2,3-oxidosqualene cyclase 85
In vitro metabolism of N-picolyl-3,5-dimethylbenzamides 84
Solubilization and identification of essential functional groups of Candida albicans oxidosqualene cyclase 84
Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4. Drug Metabolism and Disposition 83
Toxin-targeted design for anticancer therapy - Part I. Synthesis and biological evaluation of new thioimidate heterobifunctional reagents 81
Metabolism of 1,1-dichloro-cis-diphenylcyclopropane by rat liver microsomes 81
LC-ESI-MS/MS characterization of strophanthin-K 80
The Metabolic Fate of isoCombretastatin A-4 in Human Liver Microsomes: Identification, Synthesis and Biological Evaluation of Metabolites. 80
IN VITRO METABOLIC FATE OF COMBRETASTATIN A-4: EVIDENCE FOR THE FORMATION OF QUINONE METABOLITES 80
In vitro metabolism study of 2-isopropyl-9H-thioxanthen-9-one (2-ITX) in rat and human: Evidence for the formation of an epoxide metabolite 80
In vitro metabolism of azasqualene derivatives and their effects on aminopyrine N-demethylase activity in rat liver microsomes 80
Metabolismo in vitro della 7-(3-acetil-1,3-tiazolidin-2-ilmetil)teofillina: solfossidazione diastereoselettiva 78
The metabolic fate of the anti-Parkinsonian drug Budipine in rats 78
Thermolysis of 4-(2-azido-3-nitrophenyl)-1,4-dihydropyridines as sources of b-carboline derivatives and some related compounds 78
NO-Donor 1,4-dihydropyridine analogues of Amlodipine 78
Pharmacokinetic of an antibody-ricin conjugate administered intraperitoneally to mice 77
In vitro and in vivo phase II metabolism of combretastatin A-4: evidence for the formation of a sulphate conjugate metabolite 77
LC-MS CHARACTERIZATION OF IN VITRO METABOLISM OF COMBRETASTATIN A-4 75
Formation of lecithin-based microemulsions containing n-alkanol phosphocholines 75
LC-MS CHARACTERIZATION OF K-STROPHANTHIN 73
LC-MS ANALYSIS OF BITTER PRINCIPLES OF ARTEMISIA ABSINTHIUM L 73
Simultaneous, stability indicating, HPLC-DAD determination of guaifenesin and methyl and propyl-parabens in cough syrup 73
Metabolism of 7-(1,3-thiazolidin-2-ylmethyl)theophylline by rat liver microsomes: evidence for a monooxygenase-dependent step in 1,3-thiazolidine ring cleavage 73
Lack of in vitro interactions using human liver microsomes between rabeprazole and anticancer drugs 72
Metabolism of 7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine (ABC-99) by rat liver microsomes: diastereoselective metabolism of the 1,3-dithiolane ring 72
IN VITRO METABOLISM STUDY OF ISOPROPYL-9H-THIOXANTHEN-9-ONE (ITX) IN RAT AND HUMAN LIVER MICROSOMES 68
In vivo metabolism of the anti-inflammatory agent 2-(5-ethyl-pyridin-2-yl)benzimidazole (KB-1043) 68
Totale 10.758
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.676
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022866 0 27 161 144 46 5 79 20 50 65 91 178
2022/20231.713 114 53 80 71 145 187 48 110 794 8 56 47
2023/2024431 47 33 34 7 78 3 98 14 0 14 36 67
2024/20251.038 33 20 43 24 40 90 133 54 276 118 31 176
2025/20263.522 165 119 259 515 341 270 474 614 226 312 174 53
2026/2027364 154 210 0 0 0 0 0 0 0 0 0 0
Totale 10.879